BioCentury
ARTICLE | Company News

Endo to acquire Par for $8B

May 19, 2015 12:29 AM UTC

Endo International plc (NASDAQ:ENDP; TSX:ENL) will acquire Par Pharmaceutical Holdings Inc. (Woodcliff Lake, N.J.) from investment firm TPG for about $8 billion, including $6.5 billion in cash and 18 million Endo shares. TPG acquired Par in 2012 for $1.9 billion.

Endo said the acquisition will bolster its generics business. The companies expect the deal to close next half and Endo expects it to be accretive to EPS in the first year. ...